Finet JE - Search Results

1

Fusion of Anthopleurin-B to AAV2 increases specificity of cardiac gene transfer.

Finet JE, Wan X, Donahue JK. Finet JE, et al. Virology. 2018 Jan 1;513:43-51. doi: 10.1016/j.virol.2017.10.006. Epub 2017 Oct 12. Virology. 2018. PMID: 29032346 Free PMC article.

2

Information learned from animal models of atrial fibrillation.

Finet JE, Rosenbaum DS, Donahue JK. Finet JE, et al. Cardiol Clin. 2009 Feb;27(1):45-54, viii. doi: 10.1016/j.ccl.2008.09.005. Cardiol Clin. 2009. PMID: 19111763 Free PMC article. Review.

3

Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation.

Igarashi T, Finet JE, Takeuchi A, Fujino Y, Strom M, Greener ID, Rosenbaum DS, Donahue JK. Igarashi T, et al. Among authors: finet je. Circulation. 2012 Jan 17;125(2):216-25. doi: 10.1161/CIRCULATIONAHA.111.053272. Epub 2011 Dec 8. Circulation. 2012. PMID: 22158756 Free PMC article.

4

Calcium/calmodulin-dependent protein kinase II causes atrial structural remodeling associated with atrial fibrillation and heart failure.

Liu Z, Finet JE, Wolfram JA, Anderson ME, Ai X, Donahue JK. Liu Z, et al. Among authors: finet je. Heart Rhythm. 2019 Jul;16(7):1080-1088. doi: 10.1016/j.hrthm.2019.01.013. Epub 2019 Jan 14. Heart Rhythm. 2019. PMID: 30654134 Free PMC article.

5

Management of Heart Failure in Cancer Patients and Cancer Survivors.

Finet JE. Finet JE. Heart Fail Clin. 2017 Apr;13(2):253-288. doi: 10.1016/j.hfc.2016.12.004. Heart Fail Clin. 2017. PMID: 28279414 Review.

6

Temporal Trends of Cardiac Outcomes and Impact on Survival in Patients With Cancer.

Hussain M, Hou Y, Watson C, Moudgil R, Shah C, Abraham J, Budd GT, Tang WHW, Finet JE, James K, Estep JD, Xu B, Hu B, Cremer P, Jellis C, Grimm RA, Greenberg N, Popovic ZB, Cho L, Desai MY, Nissen SE, Kapadia SR, Svensson LG, Griffin BP, Cheng F, Collier P. Hussain M, et al. Among authors: finet je. Am J Cardiol. 2020 Dec 15;137:118-124. doi: 10.1016/j.amjcard.2020.09.030. Epub 2020 Sep 28. Am J Cardiol. 2020. PMID: 32991858 Free PMC article.

7

Pharmacologic Management of Cancer Therapeutics-Induced Cardiomyopathy in Adult Cancer Survivors.

Finet JE, Wiggers GA. Finet JE, et al. Curr Heart Fail Rep. 2018 Aug;15(4):270-279. doi: 10.1007/s11897-018-0401-0. Curr Heart Fail Rep. 2018. PMID: 29951883 Review.

8

All-cause mortality predicted by peak oxygen uptake differs depending on spirometry pattern in patients with heart failure and reduced ejection fraction.

Van Iterson EH, Cho L, Tonelli A, Finet JE, Laffin LJ. Van Iterson EH, et al. Among authors: finet je. ESC Heart Fail. 2021 Aug;8(4):2731-2740. doi: 10.1002/ehf2.13342. Epub 2021 May 1. ESC Heart Fail. 2021. PMID: 33932128 Free PMC article.

9

Protecting the heart in cancer therapy.

Finet JE, Tang WHW. Finet JE, et al. F1000Res. 2018 Sep 28;7:F1000 Faculty Rev-1566. doi: 10.12688/f1000research.15190.1. eCollection 2018. F1000Res. 2018. PMID: 30345014 Free PMC article. Review.

10

Alveolar Volume Impairment Affects the Prognostic Value of Peak Exercise Oxygen Uptake in Heart Failure With Reduced Ejection Fraction.

Van Iterson EH, Cho L, Tonelli A, Finet JE, Laffin LJ. Van Iterson EH, et al. Among authors: finet je. J Cardiopulm Rehabil Prev. 2022 Nov 1;42(6):E103-E105. doi: 10.1097/HCR.0000000000000702. Epub 2022 Jun 7. J Cardiopulm Rehabil Prev. 2022. PMID: 35861950 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters